Drugs / Activated and expanded natural killer cells (NKAEs)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02074657 | Apr 2014 → Sep 2016 | acute leukemia | Hospital Universitario La Paz | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Activated and expanded natural killer cells (NKAEs) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02074657 ↗ |
| Known as | NKAE | “Here we present a post-hoc analysis assessing safety and efficacy of infusing activated and expanded Natural Killer cells (NKAE) from haploidentical donors in patients from 2...” PMID 29477379 ↗ Feb 2018 |
| Modality | Cell therapy | “We conclude that infusion of fresh NKAE cell therapy is feasible and safe in heavily pretreated pediatric population” PMID 29477379 ↗ Feb 2018 |